The Russian GVN Center includes leading research, clinical and non-governmental institutions working in virology. The aims of the Russian GVN are to:
• Protect public health and safety;
• Provide information for decision-making on public health issues;
• Elaborate strategies to prevent and treat viral diseases;
• Increase the interaction on virology, including at the international level.
Important viruses at the Center include: HIV, HBV, HCV, CMV, and EBV.
The key areas of work are genetics and molecular biology of microorganisms, epidemiology, basic and practical immunology and allergology, immunogenetics, the physiology of the immune system, immune nano- and biotechnology (new generation of vaccines, therapeutic immuno-modulatory drugs and diagnostic tools), and clinical trials of diagnostic, therapeutic and preventive medications.
Center Director: Dr. Alexey Mazus
Affiliated Researchers: Rakhim M. Khaitov, Alexander L. Gintsburg, Boris S. Naroditsky, Nikolay D. Yuschuk, Alexander S. Kononets, Andrey P. Kozlov, Yuliya K. Plotnikova
Russian Smorodintsev Research Institute of Influenza (SRII) is involved in the detailed research of Influenza and other Acute Respiratory Diseases (ARD). A.A. Smorodintsev founded the Research Institute of Influenza and headed it from 1967 until 1972. He was the first to succeed in isolating the influenza virus in Russia in 1934. In addition, Smorodintsev was the first who created the live attenuated vaccine against influenza.
SRII expertise includes: molecular and genetic research of influenza and ARI viruses, epidemiological and etiological research of influenza and ARI, studies of viral pathogenesis and morphology of viruses, development of diagnostic tests and reagents for influenza and ARI, influenza vaccine composition and fabrication, screening of novel antiviral preparations, clinical therapy and prevention research, novel RNA and DNA vaccines and medicines R&D.
15/17 PROF. POPOVA STREET, ST-PETERSBURG, RUSSIA, 197376
SRII facilities: modern laboratories with up-to-date scientific equipment, Biosafety
Level (BSL) 3 facilities, animal facility, unique influenza, ARI and other viral strains repository (starting since 1930 with more than 20,000 strains),dedicated clinical department, pilot production facilities for diagnostic reagents and vaccine candidate, Scientific Advisory Board and thesis committee (Virology).
SRII is the research center and base for the training of highly qualified specialists (graduate and postgraduate traineeship) in three disciplines: Virology, Epidemiology and Infection Diseases and provides annual training courses in molecular virology (Peter the GreatSt. Petersburg Polytechnic University), Virology (jointly with the I. Mechnikov North-Western State Medical University, St. Petersburg) and internships and training programs for laboratory specialists from CIS and Baltic Region states (with support from WHO/Europe).
Since 1971 the Institute has collaborated with the WHO as well as CDC, and neighboring Russian countries, and continues vaccine clinical trials and antiviral research. As the WHO National Influenza Center the institute actively contributes to the global influenza surveillance within the Global Influenza Surveillance System (GISRS). There is an active exchange of strains and diagnostic reagents with WHO collaborating centers for influenza in the United States (CDC, Atlanta) and the United Kingdom (F. Crick Institute, Influenza Worldwide Center, London). Information is exchanged, sequencing data and phylogenetic analysis of influenza viruses circulating in various regions of Russia are deposited in the EpiFlu GISAID database.
The institute is widely open for local and international cooperation and collaboration.
Center Director: Dr. Andrey V Vasin
Center Deputy Director: Dr. Daria M Danilenko
Affiliated Researchers: Dmitry A. Moshkoff, Dmitry A. Lioznov, Andrey P. Kozlov, Dr. Olga L. Vlasova, Dr. Marina А. Stukova, Dr. Andrey Yu Egorov, Dr. Maria V. Sergeeva
Administration: Marina N Dmitrieva
725 West Lombard St
Baltimore, MD 21201